Pre-treatment rehabilitation program for cancer patients
Official title: Cancer Survival and Outcomes Impact of Universal Disability Screening and Cancer Rehabilitation Referral Among Adults With Cancer Referred to the University of North Carolina
Run by UNC Lineberger Comprehensive Cancer Center · NCT06674889 · Data updated 2026-11-12
This study is testing whether a special exercise and support program before cancer treatment can help high-risk patients feel better and have improved results during their care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | January 21, 2025 |
| Main results expected | January 20, 2027 |
| Study ends | January 20, 2027 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT06674889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult cancer patients aged 18 and older who have been screened and referred to oncology clinics with high-risk features.
✕Probably not a fit
Patients who are unable to provide informed consent or have unstable medical comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot health services interventional study aims to evaluate the effectiveness of a pre-treatment rehabilitation program for adult cancer patients identified as high-risk. Patients will be screened and referred to participate in tailored prehabilitation interventions, with the study tracking functional outcomes and quality of life. The goal is to demonstrate the benefits of prehabilitation on the cancer treatment continuum, hypothesizing that those in the intervention group will experience better outcomes compared to those who do not receive the intervention.
Why it matters
Potential benefit: If successful, this program could significantly improve the functional outcomes and quality of life for cancer patients undergoing treatment.
How similar studies have gone: Other studies have shown promising results with prehabilitation approaches in cancer care, indicating potential for success in this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information. * Subjects are willing and able to comply with study procedures based on the judgement of the investigator. * Age ≥ 18 years at the time of consent. * The subject has been screened by the Central Oncology Navigation Program and referred to cancer care at the University of North Carolina Medical Center. * Answer "yes" to at least one of the following screening questions: 1. Does your health interfere with any of your activities of daily living (ADLs)? 2. Have you fallen, or do you feel unsteady while standing or walking? 3. Do you use durable medical equipment (DME)? 4. Are you interested in increasing the amount you exercise? Exclusion Criteria: * Inability to read and understand the English language. * Psychological or other disability resulting in the inability to provide informed consent. * Unstable medical comorbidity that precludes safe participation in an exercise program, in the judgment of the clinical investigator. * Prisoners and other institutionalized individuals.
Where it's running
-
The N.C. Cancer Hospital
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Christopher E Jensen, MD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Devin McCarthy
- Email: devin_mccarthy@med.unc.edu
- Phone: 919-966-4432
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding targeted GRID-style radiation to standard palliative therapy for unresectable solid tumors
This study tests whether adding spatially fractionated radiation therapy to standard palliative radiation helps relieve symptoms in patients with unresectable solid tumors.
-
First-in-human imaging of EphA2 using 68Ga-DOTA-EphA2 PET/CT
This study tests a new 68Ga PET tracer designed to image EphA2 expression in adults with suspected or confirmed malignant tumors.
-
Irradiated tumor-and-stroma vaccine for advanced solid tumors
This Phase 1 test will try an irradiated vaccine made from tumor cells and nearby stromal cells, with or without GM-CSF, to see if it is safe and can stimulate the immune system in people with advanced solid tumors.
-
Al18F‑NOTA‑FAPI PET imaging for cancer, cardiovascular, and autoimmune conditions
This trial will test a new PET tracer called Al18F‑NOTA‑FAPI to image fibroblast activity in adults with cancer, heart disease, or autoimmune conditions and in healthy volunteers to see how safe and useful it is for guiding care.
-
Psychological distress and its effects on treatment adherence, outcomes, and quality of life in people with cancer
This study will try to see if anxiety and depression change how adults with cancer stick to treatment, their health outcomes, and their quality of life over three years.
-
Evaluating central oncology navigation and a new oncology research navigator for cancer care
This study is testing if a new support system for cancer patients can help improve their care experience, focusing on those newly diagnosed with certain types of cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.